Filing Details
- Accession Number:
- 0001179110-18-006568
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-10 17:04:40
- Reporting Period:
- 2018-05-08
- Accepted Time:
- 2018-05-10 17:04:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733094 | Young Kwon | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Svp, Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-08 | 1,409 | $0.00 | 143,320 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-08 | 493 | $18.08 | 142,827 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-05-09 | 5,000 | $13.26 | 147,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-09 | 5,000 | $21.90 | 142,827 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-05-09 | 2,000 | $15.44 | 144,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-09 | 2,000 | $21.90 | 142,827 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-05-09 | 2,000 | $12.58 | 144,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-09 | 2,000 | $21.90 | 142,827 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-05-09 | 3,000 | $17.96 | 145,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-09 | 3,000 | $21.90 | 142,827 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-05-09 | 2,000 | $13.02 | 144,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-05-09 | 2,000 | $21.90 | 142,827 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-09 | 296 | $21.90 | 142,531 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-05-09 | 204 | $21.90 | 142,327 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2018-05-08 | 1,409 | $0.00 | 1,409 | $0.00 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-05-09 | 5,000 | $0.00 | 5,000 | $13.26 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-05-09 | 2,000 | $0.00 | 2,000 | $15.44 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-05-09 | 2,000 | $0.00 | 2,000 | $12.58 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-05-09 | 3,000 | $0.00 | 3,000 | $17.96 |
| Common Stock | Stock Option(Right to Buy) | Disposition | 2018-05-09 | 2,000 | $0.00 | 2,000 | $13.02 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,504 | No | 4 | M | Direct | ||
| 52,000 | 2015-02-22 | 2021-02-22 | No | 4 | M | Direct |
| 26,000 | 2016-02-14 | 2022-02-14 | No | 4 | M | Direct |
| 26,800 | 2017-02-19 | 2023-02-19 | No | 4 | M | Direct |
| 31,986 | 2018-02-18 | 2024-02-18 | No | 4 | M | Direct |
| 33,725 | 2018-02-18 | 2025-02-18 | No | 4 | M | Direct |
Footnotes
- Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- Restricted Stock Units convert into common stock on a one-for-one basis.
- Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.
Billionaire Hedge Funds
